Abstract:Background Natural killer (NK) cells and T cells are important therapeutic populations that can target and eliminate cancer cells. Although human NK/T cell populations can be reconstituted in immunodeficient mice to test novel NK and/or T cell modulators, the time window for experimentation is often limited due to GvHD (graft-versus-host disease) complications. Moreover, human NK cell development and maturation is limited in such models due to the lack of human IL15. Previously, we disrupted the murine B2m allele in immunodeficient (B-NDG) mice and fused the FcRn coding region to the modified allele to ensure normal IgG metabolism, thereby generating B-NDG B2m KO mice plus. Here, we generated B-NDG B2m KO mice plus expressing human IL15 for improved NK cell engraftment and survival following human PBMC reconstitution. Methods We introduced the human IL15 coding sequence into the murine IL15 locus, and crossed the mice with B-NDG B2m KO mice plus to generate B-NDG B2m plus/hIL15 mice. Expression of B2m and IL15 protein in B-NDG B2m plus/hIL15 mice was evaluated using flow cytometry and ELISA, respectively. To assess human T cell and NK cell reconstitution, B-NDG B2m plus/hIL15 mice and B-NDG mice were engrafted with human PBMCs. To examine the engraftment capacity of hematopoietic stem cells (HSCs), B-NDG B2m plus/hIL15 or B-NDG hIL15 neonates were injected with human CD34+ cells (3E4) from mixed donors via the facial vein. Blood from engrafted mice was sampled for flow cytometric analysis. Survival and weight were recorded to monitor GvHD and incidence of other health-related effects. Results ELISA confirmed expression of human IL15, but not murine IL15 in B-NDG B2m plus/hIL15 mice. PBMC engraftment did not induce GvHD in B-NDG B2m plus/hIL15 mice over the 4 week study, while the survival rate of B-NDG mice was 20% after 2 weeks. Importantly, human T and NK cells were successfully reconstituted after PBMC engraftment. In newborn mice engrafted with CD34+ HSCs, higher levels of NK and myeloid cell reconstitution were observed in B-NDG B2m plus/hIL15 mice compared to B-NDG hIL15 mice. While all engrafted B-NDG hIL15 mice survived to 20 weeks, survival of B-NDG B2m KO/hIL15 mice dropped to 80% past week 12, and below 70% past week 18. Conclusions We established an immunodeficient humanized IL15 model that lacks B2m to reduce GvHD incidence upon PBMC engraftment. B-NDG B2m plus/hIL15 mice provide an ample therapeutic window for testing novel NK cell or T cell modulators in vivo. Ethics Approval All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Biocytogen Beijing Co., Ltd.

B-Cell Reconstitution And Xenoreactive Anti-Pig Natural Antibody Production In Severe Combined Immunodeficient Mice Reconstituted With Immunocompetent B Cells From Varying Sources

Allogeneic and xenogeneic lymphoid reconstitution in a RAG2 -/- IL2RG y/- severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation

Improved B cell development in humanized NOD -scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3

Assessment Of Re-188 Marked Anti Mhc Class Ii Antibody By Peripheral Blood Mononuclear Cells Stimulated By Donor Alloantigen

Characterization of xenogeneic mouse-to-rat bone marrow chimeras. I. Examination of hematologic and immunologic function

Appearance of human plasma cells following differentiation of human B cells in NOD/SCID mouse spleen.

Increased soluble CD154 (CD40 ligand) levels in xenograft recipients correlate with the development of de novo anti-pig IgG antibodies

Immunological Response of Pigs to Human Cells, Including Issues Such as the Production of Natural Antibodies in Newborns

In vitro stimulation of antibody formation by peritoneal cells. 3. Effect of active immunization on the subsequent in vitro performance of peritoneal and spleen cells

Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency

Characterization Of Anti-Gal Antibody-Producing Cells Of Baboons And Humans

Tolerization of Anti-Galalpha1-3gal Natural Antibody-Forming B Cells by Induction of Mixed Chimerism.

Mixed xenogeneic porcine chimerism tolerizes human anti-pig natural antibody-producing cells in a humanized mouse model

The genetic basis of natural antibody titers of young healthy pigs and relationships with disease resilience

Fetal bone engraftment reconstitutes the immune system in pigs with severe combined immunodeficiency

Mac-1-Negative B-1b Phenotype of Natural Antibody-Producing Cells, Including Those Responding to Gal Alpha 1,3gal Epitopes in Alpha 1,3-Galactosyltransferase-deficient Mice

16 A Novel B2m-deficient Immunodeficient Model Expressing Human IL15 for Preclinical Evaluation of T Cell and NK Cell-Based Therapies

Eliminating Xenoantigen Expression on Swine RBC

Immunoglobulin-Secreting Cells of Maternal Origin Can Be Detected in B Cell-Deficient Mice

Antigen-Specific Single B Cell Sorting and Monoclonal Antibody Cloning in Guinea Pigs

Studies of innate immune systems against human cells